Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04599101 · ClinicalTrials.gov registry record · NA

Nasal Suction in Infants With Bronchiolitis Using a NoseFrida vs. Bulb Syringe

A NA study, sponsored by Corewell Health East.

Terminated
Registry status
NA
Development phase
21
Enrollment target

NCT04599101 is a NA study that was terminated before completion, run by Corewell Health East. The registered enrollment target is 21 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04599101, a NA study, was terminated before completion, sponsored by Corewell Health East.

TERMINATED
Registry status
NA
Development phase
21 participants
Enrollment target

Study Summary

This research study will evaluate the difference in effectiveness of nasal suction between two different suction devices (NoseFrida and bulb syringe) in infants that have bronchiolitis. Bronchiolitis (a virus infection that goes into the lungs, which subsequently causes difficulty breathing, difficulty sleeping, and difficulty eating and drinking in children) is a common infection in young children. The caregiver-participants will be supplied with a suction devices (either NoseFrida and bulb syringe suction). The device should be used to clear nasal secretions as needed following discharge from the Emergency Center. The participants will be asked to use either a NoseFrida device or a bulb syringe. Caregivers will monitor how well their baby is breathing, eating/drinking, sleeping and how many times the baby has been seen by a medical provider in the 5 days post discharge from the Emergency Center. Post discharge, caregivers will complete a REDCAP survey asking questions about how their baby has been doing over the first 5 days following hospital discharge. REDCAP survey will be sent day 5 and again on day 7 if not completed. This completes study involvement.

Interventions

  • DEVICE Nose Frida nasal suction device
  • DEVICE Bulb syringe nasal suction device

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2020-11-21
Est. Completion 2023-04-18
Phase NA

Sponsor

Corewell Health East

106 total trials

What the Registry Record Tells You About NCT04599101

The ClinicalTrials.gov registry entry for NCT04599101 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Nose Frida nasal suction device is the first listed.

NCT04599101 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04599101 about?

NCT04599101 is a clinical study titled "Nasal Suction in Infants With Bronchiolitis Using a NoseFrida vs. Bulb Syringe". This research study will evaluate the difference in effectiveness of nasal suction between two different suction devices (NoseFrida and bulb syringe) in infants that have bronchiolitis. Bronchiolitis (a virus infection that goes into the lungs, which subsequently causes difficulty breathing, difficu...

What is the current status of trial NCT04599101?

This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2020-11-21. Estimated completion is 2023-04-18.

What interventions are being tested in trial NCT04599101?

The interventions under investigation include: Nose Frida nasal suction device (DEVICE), Bulb syringe nasal suction device (DEVICE).

Who is sponsoring clinical trial NCT04599101?

This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.